tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GRCE Stock Latest News

Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
The FlyGrace Therapeutics reports Q3 EPS (14c) vs (36c) last year
1M ago
GRCE
Ten new option listings and two option delistings on January 22nd
PremiumThe Fly
Ten new option listings and two option delistings on January 22nd
2M ago
AVR
INR
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
PremiumCompany Announcements
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
2M ago
8K
GRCE
Grace Therapeutics Reports Q2 2026 Results and FDA Progress
PremiumCompany Announcements
Grace Therapeutics Reports Q2 2026 Results and FDA Progress
4M ago
GRCE
Grace Therapeutics Announces Q2 2026 Financial Results
PremiumCompany Announcements
Grace Therapeutics Announces Q2 2026 Financial Results
4M ago
8K
GRCE
Grace Therapeutics reports Q2 EPS (6c) vs (30c) last year
PremiumThe FlyGrace Therapeutics reports Q2 EPS (6c) vs (30c) last year
4M ago
GRCE
Grace Therapeutics Secures $4M Through Warrant Exercise
Premium
Company Announcements
Grace Therapeutics Secures $4M Through Warrant Exercise
5M ago
8K
GRCE
Grace Therapeutics secures $4M through common warrant exercises
Premium
The Fly
Grace Therapeutics secures $4M through common warrant exercises
5M ago
GRCE
Grace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial
PremiumThe Fly
Grace Therapeutics announces presentation of Phase 3 STRIVE-ON safety trial
6M ago
GRCE
Grace Therapeutics Secures New Patent for GTx-104
PremiumCompany Announcements
Grace Therapeutics Secures New Patent for GTx-104
6M ago
8K
GRCE
Grace granted sixth U.S. patent covering I.V. dosing regimen for GTx-104
PremiumThe Fly
Grace granted sixth U.S. patent covering I.V. dosing regimen for GTx-104
6M ago
GRCE
Grace Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Grace Therapeutics Holds Annual Stockholders Meeting
6M ago
8K
GRCE
FDA Accepts Grace Therapeutics’ NDA for GTx-104
PremiumCompany AnnouncementsFDA Accepts Grace Therapeutics’ NDA for GTx-104
7M ago
8K
GRCE
Grace Therapeutics announces U.S. FDA accepted NDA for GTx-104 for review
Premium
The Fly
Grace Therapeutics announces U.S. FDA accepted NDA for GTx-104 for review
7M ago
GRCE
Grace Therapeutics Reports Q2 2025 Earnings and Strategic Focus
Premium
Company Announcements
Grace Therapeutics Reports Q2 2025 Earnings and Strategic Focus
7M ago
GRCE
Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year
PremiumThe Fly
Grace Therapeutics reports Q1 EPS (21c) vs (24c) last year
7M ago
GRCE
Grace Therapeutics management to meet virtually with Craig-Hallum
PremiumThe Fly
Grace Therapeutics management to meet virtually with Craig-Hallum
8M ago
GRCE
Grace Therapeutics Submits New Drug Application to FDA
PremiumCompany Announcements
Grace Therapeutics Submits New Drug Application to FDA
9M ago
8K
GRCE
Grace Therapeutics announces submission to U.S. FDA of NDA for GTx-104
PremiumThe Fly
Grace Therapeutics announces submission to U.S. FDA of NDA for GTx-104
9M ago
GRCE
Grace Therapeutics Reports Promising Drug Development Progress
PremiumCompany AnnouncementsGrace Therapeutics Reports Promising Drug Development Progress
9M ago
GRCE
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
Premium
The Fly
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
9M ago
BK
AMD
Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)
Premium
The Fly
Grace Therapeutics reports FY25 EPS (79c), consensus ($1.66)
9M ago
GRCE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >